Intelligent Investor

Challenger International Limited (ASX: CLI1) - Share Price and Research

DELISTED

CLI1 General Information +

ASX Code CLI1
Website N/A
Industry/Sector Research & Consulting Services
Market Cap ($M) n/a
CLI1 Share Price N/A
Day High N/A
Day Low N/A
Last Close N/A
CLI1 Share Price Movement N/A
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

CLI1 Related Research

Challenger International Limited (CLI1) Upcoming Dividends & Yields

There are no dividends for Challenger International Limited (CLI1). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Challenger International Limited (CLI1) Recent ASX Announcements

There are no announcements from Challenger International Limited (CLI1). Please use our ASX Announcements tool to search for announcements across all ASX-listed securities.

CLI1 Directors

Name Position Start Date
Mr Alastair Provan Alternate Director for J Service and B Shanahan 1 Jan 0001
Mr James (Jim) Glen Service Deputy Chairman 1 Jan 0001
Ms Brenda Mary Shanahan Non-Executive Director 1 Jan 0001
Mr Colin Morton Bell Non-Executive Director 1 Jan 0001

Challenger International Limited (CLI1) Changes in Directors' Interest & Trades

There are no directors' trades from Challenger International Limited (CLI1). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CLI1 Management

Name Position
Christopher (Chris) Edgar Cuffe Acting Chief Executive Officer
Tim Foster Chief Financial Officer
Gary Simon Chief Operating Officer
David H Slatyer Company Secretary

CLI1 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (CLI1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
53,220,598 (18.46%) Cavalane Holdings Pty Ltd
30,814,930 (10.69%) Universal Equity Pty Ltd
18,546,007 (6.43%) Bell Securities Limited
14,939,126 (5.24%) Hudson Conway Investments Pty Ltd

FAQs about Challenger International Limited (CLI1)

Relative to the previous close share price of , Challenger International Limited's (CLI1) current share price of constitutes a movement of or . Challenger International Limited's (CLI1) share price movement is when compared to 7 days ago and is n/a below CLI1's 52-week high of n/a.

Challenger International Limited (CLI1) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for CLI1 is a ratio that tells you the percentage of Challenger International Limited's (CLI1) share price that it pays out in dividends each year.

Challenger International Limited (CLI1) will release its next Annual Report on n/a. Challenger International Limited's (CLI1) last annual report was released on n/a.

Challenger International Limited (CLI1) is classified as Industrials. Other companies in this sector include Transurban Group (TCL), Brambles Limited (BXB), Reece Limited (REH), and Computershare Limited (CPU).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.